Detalhe da pesquisa
1.
Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity.
Nat Mach Intell;
5(8): 861-872, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37829001
2.
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer.
Front Immunol;
14: 1188831, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37744342
3.
Persistent mutation burden drives sustained anti-tumor immune responses.
Nat Med;
29(2): 440-449, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36702947
4.
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
Front Oncol;
12: 945798, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35992816
5.
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Nat Med;
27(11): 1910-1920, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34750557
6.
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
Cancer Immunol Res;
8(3): 396-408, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31871119
7.
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma.
Cell Rep Med;
1(8): 100139, 2020 11 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33294860